Thursday, March 31, 2022

VivoSense Gets $25M For Wearables

Newport Beach-based VivoSense, a company using wearable sensors for the clinical trials market, says it has raised $25M in a Series A funding round. The roudn came from Debiopharm and the Perceptive Xontogeny Venture (PXV) Fund. The company said it is developing an informatics platform for data analysis from wearable and connected technologies. The company is led by CEO Dudley Tabakin. The company said it will use the funding to expand and refine its platform.